COL3A1 and Ehlers-Danlos syndrome: Symptoms include dermal manifestations, joint hyper-mobility and, in severe cases, spontaneous rupture of the bowel or large arteries.44 COL3A1 mutations similar to those underlying EDS are unlikely to be disease-causative in patients with GORD due to the milder phenotypic expression seen in GORD compared with EDS.